Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-29 Sale |
2022-08-31 4:55 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12.72 | $25,435 | 206,710 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 4:06 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,669 | $13.78 | $64,362 | 119,793 (Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 6:28 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
11,655 | $13.08 | $152,432 | 347,233 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:53 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
600 | $13.02 | $7,814 | 368,209 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 4:03 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12 | $24,000 | 208,710 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:02 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
7,714 | $13 | $100,282 | 64,893 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:02 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
4,000 | $12 | $48,000 | 210,710 (Direct) |
View |
| 2022-06-02 Purchase |
2022-06-06 5:07 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
40,947 | $6.3682 | $260,760 | 4,501,658 (Indirect) |
View |
| 2022-05-20 Purchase |
2022-05-24 6:39 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
48,509 | $5.8226 | $282,447 | 4,465,029 (Indirect) |
View |
| 2022-05-16 Purchase |
2022-05-18 5:38 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
71,944 | $5.9866 | $430,701 | 4,421,689 (Indirect) |
View |
| 2022-01-12 Purchase |
2022-01-13 7:53 pm |
Entrada Therapeutics Inc. | TRDA | Crowley John F Director |
5,000 | $9.715 | $48,575 | 37,864 (Indirect Direct) |
View |
| 2021-11-02 Purchase |
2021-11-05 08:49 am |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 9:10 pm |
Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 9:00 pm |
Entrada Therapeutics Inc. | TRDA | Redmile Group LLC Green Jeremy Redmile Biopharma Investments III L.P. 10% Owner |
1,000,000 | $20 | $20,000,000 | 1,954,420 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 5:38 pm |
Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner |
100,000 | $20 | $2,000,000 | 4,425,784 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 5:37 pm |
Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
100,000 | $20 | $2,000,000 | 4,425,784 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-01 Option Award |
2022-09-06 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
5,172 | $0 | 20,716 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
5,632 | $0 | 70,525 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:31 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
15,125 | $0 | 221,835 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:06 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,117 | $2.1 | 119,793 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:06 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,117 | $0 | 119,793 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 6:28 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,972 | $2.1 | 347,233 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 6:28 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,972 | $0 | 347,233 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 6:53 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
300 | $2.1 | 368,209 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 6:53 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
300 | $0 | 368,209 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:20 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
33,019 | $0 | 33,019 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:19 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
31,032 | $0 | 31,032 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:18 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
33,788 | $0 | 33,788 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:16 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
34,763 | $0 | 34,763 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
90,750 | $0 | 90,750 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:11 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Foley Todd Director 10% Owner |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:02 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | KIM PETER S Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:02 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Thistle Mary Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Crowley John F Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:11 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
78,838 | $0 | 140,182 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:10 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
81,113 | $0 | 225,875 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:09 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
72,407 | $0 | 77,607 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:09 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
77,044 | $0 | 86,579 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:08 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
211,750 | $0 | 396,210 (Direct) |
View |
| 2022-01-13 Exercise |
2022-01-18 6:01 pm |
N/A 2029-05-14 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
10,000 | $0 | 584,449 (Direct) |
View |
| 2022-01-13 Exercise |
2022-01-18 6:01 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
10,000 | $1.74 | 584,449 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-29 4:26 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
5,200 | $2.1 | 147,922 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-29 4:26 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
5,200 | $0 | 147,922 (Direct) |
View |
Ownership |
2021-12-16 6:35 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
0 | $0 | 4,704,419 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-05 08:49 am |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
3,827,224 | $0 | 1,132,357 (Indirect) |
View |
Ownership(A) |
2021-11-05 08:48 am |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
0 | $0 | 2,371,739 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 9:45 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
2,813,525 | $0 | 2,813,525 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 9:10 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
31,520,600 | $0 | 1,132,357 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 9:00 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Redmile Group LLC Green Jeremy Redmile Biopharma Investments III L.P. 10% Owner |
954,420 | $0 | 1,954,420 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 5:38 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | MPM BIOVENTURES 2018 L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC 10% Owner |
35,626,700 | $0 | 4,425,784 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 5:37 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
35,626,700 | $0 | 4,425,784 (Indirect) |
View |